Germline mutations in the TGF-beta and Wnt signalling pathways are a rare cause of the "multiple" adenoma phenotype.
作者信息
Lipton L, Sieber O M, Thomas H J W, Hodgson S V, Tomlinson I P M, Woodford-Richens K
出版信息
J Med Genet. 2003 Apr;40(4):e35. doi: 10.1136/jmg.40.4.e35.
Abstract
摘要
相似文献
1
Germline mutations in the TGF-beta and Wnt signalling pathways are a rare cause of the "multiple" adenoma phenotype.
J Med Genet. 2003 Apr;40(4):e35. doi: 10.1136/jmg.40.4.e35.
2
Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Cancer Res. 2000 Aug 15;60(16):4507-12.
3
Inherited defects in the DNA glycosylase MYH cause multiple colorectal adenoma and carcinoma.
Carcinogenesis. 2003 Jul;24(7):1281-2; author reply 1283. doi: 10.1093/carcin/bgg068. Epub 2003 May 9.
4
Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
J Exp Clin Cancer Res. 2003 Jun;22(2):315-20.
5
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9719-23. doi: 10.1073/pnas.171321498. Epub 2001 Jul 31.
6
Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations.
Hum Mol Genet. 2002 Nov 1;11(23):2961-7. doi: 10.1093/hmg/11.23.2961.
7
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.
Nat Genet. 2001 Jun;28(2):184-7. doi: 10.1038/88919.
8
Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.
J Clin Endocrinol Metab. 1999 May;84(5):1716-21. doi: 10.1210/jcem.84.5.5704.
9
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Nat Genet. 2000 Mar;24(3):245-50. doi: 10.1038/73448.
10
Molecular markers of heterogeneity in colorectal cancers and adenomas.
Eur J Cancer Prev. 2002 Feb;11(1):85-97. doi: 10.1097/00008469-200202000-00013.
引用本文的文献
1
Exploring the Role of the TGF-β Signaling Pathway in Colorectal Precancerous Polyps Biochemical Genetics.
Biochem Genet. 2025 Apr;63(2):1116-1148. doi: 10.1007/s10528-024-10988-y. Epub 2024 Dec 5.
2
Transforming growth factor-β in tumour development.
Front Mol Biosci. 2022 Oct 4;9:991612. doi: 10.3389/fmolb.2022.991612. eCollection 2022.
3
Current status of the genetic susceptibility in attenuated adenomatous polyposis.
World J Gastrointest Oncol. 2019 Dec 15;11(12):1101-1114. doi: 10.4251/wjgo.v11.i12.1101.
4
SEQCHIP: a powerful method to integrate sequence and genotype data for the detection of rare variant associations.
Bioinformatics. 2012 Jul 1;28(13):1745-51. doi: 10.1093/bioinformatics/bts263. Epub 2012 May 3.
5
The Yin and Yang of bone morphogenetic proteins in cancer.
Cytokine Growth Factor Rev. 2010 Aug;21(4):299-313. doi: 10.1016/j.cytogfr.2010.06.003. Epub 2010 Aug 4.
6
Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations.
Br J Cancer. 2007 Jun 4;96(11):1729-34. doi: 10.1038/sj.bjc.6603789. Epub 2007 May 15.
7
Implication of MYH in colorectal polyposis.
Ann Surg. 2006 Dec;244(6):874-9; discussion 879-80. doi: 10.1097/01.sla.0000246937.54435.50.
8
Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas.
Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15992-7. doi: 10.1073/pnas.0407187101. Epub 2004 Nov 1.
Zotero 插件